Article

Extracellular disintegration of viral proteins as an innovative strategy for developing broad-spectrum antivirals against coronavirus

2022-11-28

Abstract excerpt

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has claimed millions of lives worldwide, not to mention innumerable losses in the global economy and disruptions in social relationships. Unfortunately, state-of-the-art treatments still lag behind the fast emergence of new variants of concern. The key to resolve this issue is to develop broad-sp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 998e972d-7bd4-5441-8a7e-605055ddba28
DOI: 10.1101/2022.11.24.517008

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Extracellular disintegration of viral proteins as an innovative strategy for developing broad-spectrum antivirals against coronavirusDOI 10.1101/2022.11.24.517008Read

Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19.Semantic proximity Read

Development of Broad‐Spectrum β‐Cyclodextrins‐Based Nanomaterials Against Influenza VirusesSemantic proximity Read

The recent outbreaks of human coronaviruses: A medicinal chemistry perspectiveSemantic proximity Read

Identification of Broad Anti-Coronavirus Chemical Agents for Repurposing Against SARS-CoV-2 and Variants of ConcernSemantic proximity Read

Developing inhibitory peptides against SARS-CoV-2 envelope proteinSemantic proximity Read

Development of Broad-spectrum β-cyclodextrins-Based Nanomaterials Against Influenza VirusesSemantic proximity Read

Preparation of antiviral multispray with cationic antimicrobial dialkyldimethyl ammonium salt and sulfobetaine against new coronaviruses (SARS-CoV-2)Semantic proximity Read

Anti‐Coronaviral Nanocluster Restrain Infections of SARS‐CoV‐2 and Associated Mutants through Virucidal Inhibition and 3CL Protease InactivationSemantic proximity Read

Novel Investigational Anti-SARS-CoV-2 Agent Ensitrelvir “S-217622”: A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus SpeciesSemantic proximity Read

Rational Development of Hypervalent Glycan Shield‐Binding Nanoparticles with Broad‐Spectrum Inhibition against Fatal Viruses Including SARS‐CoV‐2 VariantsSemantic proximity Read

Pharmacological perturbation of intracellular dynamics as a SARS-CoV-2 antiviral strategySemantic proximity Read

New Class of Broad-Spectrum Antivirals Improves Influenza Virus Vaccine DevelopmentSemantic proximity Read